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A new strain of measles virus, D4-Hamburg, was 
imported from London to Hamburg in December 2008 and 
subsequently spread to Bulgaria, where an outbreak of 
>24,300 cases was observed. We analyzed spread of the 
virus to demonstrate the importance of addressing hard-to-
reach communities within the World Health Organization 
European Region regarding access to medical care and 
vaccination campaigns. The D4-Hamburg strain appeared 
during 2009–2011 in Poland, Ireland, Northern Ireland, 
Austria, Greece, Romania, Turkey, Macedonia, Serbia, 
Switzerland, and Belgium and was repeatedly reimported 
to Germany. The strain was present in Europe for >27 
months and led to >25,000 cases in 12 countries. Spread 
of the virus was prevalently but not exclusively associated 
with travel by persons in the Roma ethnic group; because 
this travel extends beyond the borders of any European 
country, measures to prevent the spread of measles should 
be implemented by the region as a whole. 
The 53 member states of the World Health Organization (WHO) European Region (EUR) have set a goal to 
eliminate measles and rubella virus transmission by 2015 
in Europe (1). Elimination targets include 95% vaccination 
coverage with 2 doses of measles virus–containing vaccine 
(MVCV), an incidence of <1 measles case per million 
population, 80% of outbreaks associated with <10 cases, 
and transmission of indigenous or imported measles virus 
for no longer than 12 months in a defi ned region (2). Thus, 
monitoring transmission chains of measles virus is an 
indispensable tool to assess elimination progress, although 
the specifi c boundaries of the region have not yet been 
defi ned for the WHO EUR.
To comply with the goal of eliminating measles 
virus, Germany implemented a national intervention 
program against measles, mumps, and rubella (MMR) in 
1999 (3). Since then, measles incidence in Germany has 
declined. Molecular surveillance showed that endemic 
genotypes C2 (MVi/Kempten.DEU/23.00) and D6 (MVi/
Berlin.DEU/47.00) (4) were replaced rapidly by genotype 
D7 (MVi/Mainz.DEU/06.00), which circulated until the 
beginning of 2003 (5). Imported measles virus of genotypes 
B3, D4, D5, D6, D8, D9, and H1 appeared in Germany 
from 2005 onward. In 2009 and 2010, most cases were 
linked to measles virus of genotype D4, of which several 
distinct subvariants were detected.
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Measles Virus D4-Hamburg, Europe
Elimination targets have not yet been met in Germany. 
Vaccination coverage in Germany, routinely assessed 
in children 5–6 years of age during an examination 
before school entry, is still below the required 95% for 
the second dose of MVCV. Recent outbreaks showed an 
immunization gap in adolescents and young adults (6). 
Consequently, outbreaks still occur in Germany every 
year, although recently they have been more limited in 
number of cases, length of time, and extent of national 
transmission (7,8). A total of 915 measles cases were 
reported in 2008, 571 in 2009, and 780 in 2010; incidence 
was 7–10 cases/1 million population (www3.rki.de/
SurvStat/QueryFormaspx). 
The reasons for Germany’s malperformance are 
complex. Measles virus vaccination is not mandatory, and 
some groups within the German population do not comply 
with offi cial vaccination recommendations (9) because of 
philosophical or religious beliefs or fear of adverse effects 
(10). As in other countries in Europe, strategies to address 
hard-to-reach populations and improve access to medical 
care, preventive measures, and vaccination campaigns 
have not yet been developed. In this article, we describe 
exportation of a measles D4 variant from Germany and its 
subsequent circulation in Europe.
Material and Methods
Serum, urine, and oral fl uid or throat swabs were 
sent to the WHO Regional Reference Laboratory in 
Berlin according to the procedures outlined in the WHO 
LabNet manual (11). Immunoglobulin (Ig) M and IgG 
serologic testing was performed as described previously 
(12). Sequencing was performed according to WHO 
recommendations (13). Sequences were aligned by 
ClustalW (14) and further analyzed by SeqScape 2.5 and 
MEGA4 DNA analysis software (15). Phylogenetic trees 
were constructed by using the neighbor-joining method. 
Genotype assignment was performed by phylogenetic 
comparison with the measles virus reference strains as 
designated by WHO (16). The obtained sequence data, 
the genotype, the offi cial WHO measles virus sequence 
name, and relevant epidemiologic data were submitted to 
the WHO measles sequence data base, MeaNS (www.hpa-
bioinformatics.org.uk/Measles/Public/Web_Front/main.
php) or to GenBank.
Results
Outbreak Hamburg/Lower Saxony
At the end of December 2008, a 27-year-old man 
residing in the southern part of Hamburg was hospitalized 
with measles. Five other adults contracted the virus while 
waiting for treatment in the emergency room. The resultant 
outbreak fi rst affected a southern quarter (Hamburg-
Harburg) of the city of Hamburg. It spread subsequently 
into a Roma group residing in central Hamburg and to the 
neighboring federal state of Lower Saxony. The probable 
index case-patient was identifi ed as a 19-year-old Roma 
man living in Hamburg. He had stayed in London from May 
through November 2008 and became ill at the beginning of 
December with measles-like symptoms. The outbreak in 
Hamburg lasted from the end of December 2008 through 
June 2009 (17); a 4-week peak occurred in February and 
comprised 216 cases in the city of Hamburg. 
For 69% of the reported cases, the diagnosis 
was laboratory confi rmed. Complications leading to 
hospitalization were seen in 40% of the patients (pneumonia 
or otitis media). The affected age group ranged from a 
1-day-old newborn to a 54-year-old adult (median age 13.5 
years). Most frequently affected were young children, then 
young adults. Data with respect to vaccination status were 
available for 196/216 case-patients. No vaccination was 
documented for 167 persons (85%); 28 had not yet reached 
the age of vaccination (>11 months). Twenty-six (13%) 
previously unvaccinated persons had received MVCV after 
being exposed to measles virus. Three patients had received 
2 doses of MVCV. Several of the 216 cases occurred in the 
Roma ethnic community. 
Seventy-two cases of measles were reported during the 
same time in Lower Saxony. Fifty-three cases were clearly 
related to the outbreak in Hamburg. The fi rst cases in 
Lower Saxony were reported during week 2 (January) and 
the last case occurred during week 17 (April) of 2009; the 
peak of the outbreak occurred during week 14 (April). The 
connection to the Hamburg outbreak was suggested either 
by the presence of patients in the emergency department of a 
Hamburg hospital at the time in question, an epidemiologic 
link, or the result of the sequencing. Many cases occurred 
in the Roma ethnic group. 
Case-patients ranged from 7 months to 42 years of 
age (median age 15 years); adolescents and younger adults 
were the main affected age group. Forty-two (79%) case-
patients had received no measles vaccination, 10 (19%) had 
received 1 dose of MVCV, and 1 (2%) had been vaccinated 
2 times. In the latter case, primary infection with measles 
virus was confi rmed by PCR and IgM, but IgG was not 
detected. Five patients received vaccination after exposure, 
which did not prevent clinical symptoms. Overall, 47 (89%) 
of measles cases were confi rmed by laboratory testing. 
Eleven (21%) case-patients were admitted to a hospital 
with complications (e.g., pneumonia, otitis media). 
Specimens from 12 cases in Hamburg and 18 cases 
in Lower Saxony were genotyped. All case-patients were 
infected with the same D4 measles virus variant (MVs/
Ham burg.DEU/03.09/[D4], MVs/Harburg.DEU/06.09/
[D4], and MVs/Wildeshausen.DEU/21.09/[D4]), none of 
which were published in the GenBank and MeaNS databases. 
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D4-Hamburg showed 1 mismatch to other D4 measles 
virus sequences published in GenBank, MVs/Raichur.
IND/38.06/[D4]), MVi/Kolar.IND/03.07/1[D4], and MVs/
Enfi eld.GBR/14.07/[D4]; the latter is a strain endemic to 
the United Kingdom and responsible for the large outbreak 
there during 2007–2009 (Figure 1). Sequences identical to 
the Hamburg strain were subsequently identifi ed in London 
(MVs/London.GBR/5.09/[D4]).
Transmission to Bulgaria
In April 2009, after an absence of 7 years, measles 
cases began occurring in Bulgaria (18). Sequencing of 3 
specimens from the National Measles Laboratory in Sofi a 
identifi ed MVs/Shumen.BGR/15.09/1-3(D4), identical 
to D4-Hamburg. The index case-patient in the Bulgaria 
outbreak was a Roma who worked as a builder in Hamburg 
and who had visited Razgrad district in northeastern 
Bulgaria. The outbreak in Bulgaria proceeded from 
the northeast to the southwest of the country; in 2009, 
a total of 2,249 cases were reported. A marked increase 
in case numbers was reported at the end of 2009 and in 
the beginning of 2010 (19). From the start of the measles 
epidemic in April 2009 through the end of week 10 (mid-
March) of 2011, a total of 24,379 cases were reported; 24 
were fatal (20). 
The WHO Regional Reference Laboratory in 
Berlin received 20 specimens at regular intervals from 
hospitalized persons. Genotype information was obtained 
for 19/20 case-patients (online Appendix Table, www.
cdc.gov/EID/content/17/8/101994-appT.htm). All viruses 
detected showed the same sequence (MVs/Shumen.
BGR/15.09/1-3[D4], MVs/Silistra.BGR/21.09/1-4[D4], 
MVs/Blagoevgrad.BGR/02.10[D4], MVs/Plovdiv.BGR/
03.10/1-3[D4], M Vs/Plovdiv.BGR/23.10/1-5[D4]), and 
MVs/VelikoTarnovo.BGR/10.11/1-2[D4]), with the ex-
ception of MVs/Plovdiv.BGR/23.10/6[D4], characterized 
by 1 mismatch (Figure 1).
Laboratory Investigation of Measles Virus 
Samples from Bulgaria
Measles virus infection was reconfi rmed for all 20 
case-patients by positive test results for IgM, PCR, or both 
(online Appendix Table). Results were correlated with the 
clinical data for each case-patient that had been compiled 
during hospitalization. For 12 case-patients, vaccination 
status was unknown; a 7-month-old baby was unvaccinated. 
Seven case-patients (1, 7, 12, 14, 15, 17, and 18) presented 
vaccination cards that stated the date of 1 or 2 vaccinations 
with MVCV (online Appendix Table). All had positive 
IgM and PCR results; 2 had measles virus–specifi c IgG 
(case-patients 7 and 14). IgG avidity testing showed low 
avidity and thus a vaccination failure for case-patient 7. The 
equivocal IgM and the mediocre avidity of IgG in patient 
14 did not indicate a primary infection. In summary, lack 
of immunologic response despite documented vaccination 
was apparent in 6 of 7 case-patients.
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Figure 1. Phylogenetic relationships between measles viruses of 
genotype D4 recently detected in Europe. The measles virus variant 
D4-Hamburg initiated a long-lasting transmission chain spreading 
to several European countries during 2008–2011. D4-Hamburg 
belongs to the D4-Enfi eld lineage, which is genetically distinct from 
the previously widespread lineage D4-Bucharest. Phylogenetic 
analysis is based on a 456-nt sequence encoding the C-terminus of 
the measles virus nucleocapsid protein. The tree was constructed 
by the neighbor-joining method by using MacVector version 11.1.2 
software (www.macvector.com). Scale bar indicates number of 5-nt 
deviations per 1,000-nt sequence. GenBank accession numbers 
are available online (www.cdc.gov/EID/content/17/8/101994-F1.
htm).
Measles Virus D4-Hamburg, Europe
Transmission of D4-Hamburg Strain in Europe
WHO Regional Reference Laboratories in Berlin, 
Luxembourg, and London receive either specimens or 
sequence information from the national measles laboratories 
of 41 European countries. Sequencing of the 450-nt 
fragment of the N gene showed that the D4-Hamburg strain 
had further spread in Europe (Figure 2). Samples taken 
in Poland during the summer of 2009 showed infection 
with a virus identical to D4-Hamburg (Figure 1); a total 
of 54 cases were recorded during 2009, the fi rst in June 
and the last in October. All were linked to 3 outbreaks 
among Roma residents in the towns of Lodz, Pulawy, 
and Olpole Lubelskie (MVs/Lodz.POL/27.09[D4], MVs/
Pulawy.POL/28.09[D4]) (21). The virus was also exported 
to Ireland (MVs/Kerry.IRL/40.09[D4]) from the Roma 
population and from there into Northern Ireland (MVs/
Belfast.GBR/50.09[D4]), with small clusters of associated 
cases in both countries. 
In Austria, 4 cases classifi ed as D4-Hamburg–
associated were detected in March and June 2010. A 
fi rst sporadic case occurred in Graz in March. A person 
of Bulgarian nationality who was a member of the Roma 
ethnic group was infected; he was staying in Austria at the 
time (MVs/Graz.AUT/12.10[D4]). Three additional cases 
belonged to a cluster observed among persons in Vienna 
who spoke Bulgarian (MVs/Vienna.AUT/13.10[D4], MVs/
Vienna.AUT/23.10[D4], MVs/Vienna.AUT/24.10[D4]). 
D4-Hamburg was also seen in Greece, where the fi rst 
cases and clusters at the beginning of 2010 were identifi ed 
among families of Roma communities of Bulgarian 
nationality (MVs/Amaliada.GRC.12.10[D4], M Vs/Pyrgos.
GRC/19.10[D4]). The virus was then spread to persons 
of Greek nationality, mainly from Roma communities, 
reaching 91 laboratory-confi rmed measles cases in 2010. 
Moreover, 2 sporadic cases of D4-Hamburg were observed 
in 2010 in Romania (MVs/Timis.ROU/18.10/1[D4]). 
In Turkey, D4-Hamburg was detected in a tourist who 
stayed in Romania and Bulgaria before visiting Turkey 
(MVs/Istanbul.TUR/20.10/[D4]). In Serbia, D4-Hamburg 
was detected in a person with a sporadic case (MVs/Belgrad.
SRB/24.10/[D4]) and in the Roma population during an 
outbreak in Leskovac (MVs/Leskovac.SRB/08.11/1[D4]); 
13 persons were infected, of which 3 were hospitalized. 
The index case-patient was a person who returned at the 
end of November from Germany (Duisburg). Nearly 400 
cases were detected in Macedonia (MVs/Kumanovo.
MKD/35.10/1[D4], MVs/Skopje.MKD/44.10/1[D4]). Al-
though we cannot be sure that D4-Hamburg is the only 
virus contributing to the current outbreaks in Serbia and 
Macedonia, ongoing transmission of D4-Hamburg is 
indicated by the recent detection of a sporadic case of D4-
Hamburg in Switzerland (MVs/Lausanne.CHE/02.11[D4]; 
this person probably became infected in Serbia) and 
by an outbreak of >40 cases in Belgium (MVs/Ghent.
BEL/09.11/1[D4]). 
Reimportation of the D4-Hamburg Strain to Germany
 In 2010, D4-Hamburg measles virus was reimported 
to Germany. It appeared fi rst in February in Mannheim, 
where specimens from 3 case-patients showed a 
sequence identical to D4-Hamburg (MVs/Mannheim.
DEU/07.10[D4]). The virus was introduced by 8 persons 
from Bulgaria who belonged to a Turkish-speaking 
minority population, had acquired the infection in Dobrich 
(Bulgaria), and transmitted the virus to 3 relatives who 
were living in Mannheim. During June–August 2010, 48 
measles cases were reported in Munich; 28 cases occurred 
among Bulgarian Roma residents in a migrant camp in 
eastern Munich. Several of these residents worked as 
cleaning staff at hotels in Munich. From these persons and 
other hospitalized members of the affected Roma group, 
the virus spread into the general population. 
The age of case-patients in Munich ranged from 
9 months to 36 years; 7 case-patients were <7 years of 
age, and 23 were >18 years of age. One case-patient was 
hospitalized because of encephalitis. Interviews with the 
help of an interpreter showed that none of the case-patients 
had MMR vaccination documents. Therefore, vaccination 
was offered to all inhabitants of the camp. Twenty-eight 
cases were investigated at the WHO Regional Reference 
Laboratory in Berlin. Twenty-three cases were associated 
with MVs/Muenchen.DEU/22.10[D4] identical with 
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Figure 2. Transmission of the D4-Hamburg measles virus strain 
in Europe, 2008–2011. Arrows mark transmission with known 
epidemiologic link; ellipsoids mark detection without verifi ed 
epidemiologic data. IRL, Ireland; GBR, Great Britain; BEL, Belgium; 
DEU, Germany; POL, Poland; CHE, Switzerland; AUT, Austria; 
ROU, Romania; SRB, Serbia; BGR, Bulgaria; MKD, Macedonia; 
GRC, Greece; TUR, Turkey.
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D4-Hamburg, and specimens from 5 members of the 
same group were closely related to MVs/Muenchen.
DEU/23.10/2[D4]. Moreover, clusters and sporadic cases 
of D4-Hamburg were detected in several German cities, 
e.g., Eichstaett (2 cases, MVs/Eichstaett.DEU/18.10[D4]) 
and Ludwigshafen (1 case, MVs/Ludwigshafen.
DEU/21.10[D4]) in May 2010. These cases were linked 
to importation of D4-Hamburg from Bulgaria and did 
not initiate virus spread within Germany. The same virus 
variant was also detected in a cluster of cases observed in 
the city of Essen during June–July 2010. This variant was 
imported from Bulgaria by a citizen of Bulgaria (MVs/
Essen.DEU/24.10[D4]) and spread to another citizen of 
Bulgaria (MVs/Essen.DEU/25.10/1[D4]) and 6 persons 
of the general population (MVs/Essen.DEU/25.10/2[D4], 
MVs/Essen.DEU/28.10[D4]). 
From week 47 (the end of November) on, 8 cases of 
infection with D4-Hamburg occurred in Neumuenster 
in northern Germany. This outbreak occurred in a home 
for migrants mainly from Afghanistan and Serbia (MVs/
Neumuenster.DEU/47.10/1[D4]). From week 48 on, 6 
cases were seen in another home for migrants in Karlsruhe 
(MVs/Karlsruhe.DEU/48.10[D4]).
Discussion
A combination of epidemiologic data and genotyping 
results enabled us to trace the spread of measles virus D4-
Hamburg in Europe. It was imported from London at the end 
of 2008 to northern Germany (288 cases), then transmitted 
from Hamburg to Bulgaria, where, after a 7-year absence 
of measles, an outbreak of 24,379 cases occurred. This was 
the largest outbreak seen in Europe since an outbreak in the 
Ukraine in 2006 (22). 
Twenty cases from the outbreak in Bulgaria were 
sampled at different times (April and June 2009, January 
and June 2010, and March 2011) from persons in 
distinct districts. The samples were collected initially in 
northeastern and later in southwestern Bulgaria, thereby 
following the course of the outbreak. The cases were 
associated with measles virus sequences such as MVs/
Shumen.BGR/15.09[D4], corresponding to D4-Hamburg. 
The only exception was MVs/Plovdiv.BGR/23.10/6[D4], 
which showed 1 mismatch but in all probability developed 
from MVs/Plovdiv.BGR/23.10/1–5[D4]. Because the 
samples had been obtained at different times and regions, 
our analysis provides substantial evidence that D4-
Hamburg is responsible for the outbreak in Bulgaria, 
despite the small number of samples. Samples from 6 of 7 
persons showed diagnostic markers of a primary measles 
infection, although these persons had a certifi cate of prior 
measles vaccination. Our results therefore demonstrate an 
urgent need to investigate the vaccination procedures for 
ethnic minorities.
D4-Hamburg was detected subsequently in Poland (54 
cases) (21), Ireland, Northern Ireland, Austria (4 cases), 
Greece (149 cases) (23), Serbia (14 cases), Belgium (>40 
cases), and Macedonia (>400 cases). Sporadic cases were 
detected in Romania, Turkey, and Switzerland. More 
than 70 D4-Hamburg–associated cases were detected in 
Germany after 8 separate reimportations. Taken together, 
D4-Hamburg was present in Europe from December 2008 
to March 2011—that is, at least 27 full months—and 
caused >25,300 cases. Because sequencing results are not 
available quickly in most countries, this transmission chain 
is probably still ongoing. Circulation of imported measles 
virus for no longer than 12 months (and therefore endemic 
transmission according to the WHO defi nition) is a marker 
for successful elimination. We suggest, therefore, that the 
length of a given transmission chain should not be assessed 
on a national level but at the level of the all 53 countries 
within the WHO EUR.
Epidemiologic data showed that the spread of D4-
Hamburg across Europe involved predominantly persons 
from the Roma ethnic group in Bulgaria. Another 
transmission chain affecting the Roma population 
in particular was recorded in 2004 in Romania. An 
outbreak of >8,000 cases associated with MVs/Bucharest.
ROU/48.04[D4] commenced in the Roma population. 
Subsequent spread of D4-Bucharest by traveling Roma 
persons was observed until 2007 (4). The pronounced 
sequence deviation of D4-Bucharest and D4-Hamburg 
indicates the presence of at least 2 distinct and successive 
transmission chains in the Roma population. Both chains 
were long lasting and associated with a high number of 
cases, as well as several fatalities. This and other recent 
outbreaks in Roma communities (7,24,25) underline the 
need for the development of strategies to address this 
ethnic minority at the regional level and to improve their 
integration into the respective national health services. 
The lack of strategies to address reaching the hard-to-
reach communities in Europe will clearly have an adverse 
effect on the measles elimination process. In this context, 
we want to make clear that elimination of measles virus 
should not be seen exclusively as a Roma-associated 
problem. Measles virus is a highly infectious agent and will 
infect any population with low immunity rates. If itinerant 
groups are underserved by the national health sector, spread 
of measles virus is highly probable. Because measles 
outbreaks in western European countries occur mainly in 
undervaccinated groups (26), reaching the hard-to-reach is 
not the only important challenge. Thus, closing vaccination 
gaps in a setting of optional vaccination and vaccine 
skepticism is another important prerequisite that must be 
met on Europe’s path toward elimination of measles virus. 
1400 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 8, August 2011
Measles Virus D4-Hamburg, Europe
Acknowledgments
We thank Ingrid Deitemeier, Petra Kurzendoerfer, Anne 
Wolbert, and Melanie Tobler for technical assistance. We are 
also grateful to all of our colleagues in the German local health 
authorities for sending specimens of suspected measles cases, 
our colleagues in the European National Measles Laboratories of 
the WHO European Region for sharing their sequence data, and 
Richard Myers for supporting the users of the bioinformatic tools 
of the MeaNS database.
Dr Mankertz is the head of the National Reference Centre for 
Measles, Mumps, Rubella, Berlin, Germany. Her research interests 
are molecular biology and epidemiology of paramyxoviruses. 
References
  1.  Resolution EUR/RC60/R12 of the WHO Regional Committee for 
Europe. Renewed commitment to elimination of measles and ru-
bella and prevention of congenital rubella syndrome by 2015 and 
sustained support for polio-free status in the WHO European region, 
60th session [cited 2010 Dec 15]. http://www.who.int/immunization/
3_Resolution_EURO_RC60_eRes12.pdf  
  2.  World Health Organization Regional Offi ce for Europe. Eliminat-
ing measles and rubella and preventing congenital rubella infection: 
WHO European region strategic plan 2005–2010. Copenhagen, 
Denmark: The Offi ce; 2005. 




  4.  Kremer JR, Brown KE, Jin L, Santibanez S, Shulga SV, Aboudy Y, et 
al. High genetic diversity of measles virus, World Health Organiza-
tion European Region, 2005–2006. Emerg Infect Dis. 2008;14:107–
14.
  5.  Santibanez S, Tischer A, Heider A, Siedler A, Hengel H. Rapid 
replacement of endemic measles virus genotypes. J Gen Virol. 
2002;83:2699–708.
  6.  Wichmann O, Siedler A, Sagebiel D, Hellenbrand W, Santibanez S, 
Mankertz A, et al. Further efforts needed to achieve measles elimi-
nation in Germany: results of an outbreak investigation. Bull World 
Health Organ. 2009;87:108–15. doi:10.2471/BLT.07.050187
  7.  Siedler A, Tischer A, Mankertz A, Santibanez S. Two outbreaks of 
measles in Germany 2005. Euro Surveill. 2006;11:131–4.
  8.  Siedler A, Mankertz A, Ahlemeyer G, Feil F, Hornig A, Scharkus S, 
et al. Closer to the goal —efforts in measles elimination in Germany 
2010. J Infect Dis. In press 2011.
  9.  Recommendations of the German Standing Vaccination Commit-
tee (STIKO) 2010 [cited 2010 Nov 22]. http://www.rki.de/cln_151/
nn_205772/DE/Content/Infekt/EpidBull/Archiv/2010/33/Tabelle.
html 
10.  Poethko-Müller C, Ellert U, Kuhnert R, Neuhauser H, Schlaud 
M, Schenk L. Vaccination coverage against measles in German-
born and foreign-born children and identifi cation of unvaccinated 
subgroups in Germany. Vaccine. 2009;27:2563–9. doi:10.1016/j.
vaccine.2009.02.009
11.  World Health Organization. Manual for the laboratory diagnosis of 
measles and rubella virus infection, 2nd ed [cited 2010 Nov 22]. 
http://www.who.int/immunization_monitoring/LabManualFinal.pdf
12.  Tischer A, Santibanez S, Siedler A, Heider A, Hengel H. Laboratory 
investigations are indispensable to monitor the progress of measles 
elimination—results of the German Measles Sentinel 1999–2003. J 
Clin Virol. 2004;31:165–78. doi:10.1016/j.jcv.2004.05.007
13.  World Health Organization. New genotype of measles virus and up-
date on global distribution of measles genotypes. Wkly Epidemiol 
Rec. 2005;80:347–51.
14.  Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 
The CLUSTAL_X windows interface: fl exible strategies for mul-
tiple sequence alignment aided by quality analysis tools. Nucleic 
Acids Res. 1997;25:4876–82. doi:10.1093/nar/25.24.4876
15.  Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolu-
tionary Genetics Analysis (MEGA) software version 4.0. Mol Biol 
Evol. 2007;24:1596–9. doi:10.1093/molbev/msm092
16.  Update of the nomenclature for describing the genetic characteristics 
of wild-type measles viruses: new genotypes and reference strains. 
Wkly Epidemiol Rec. 2003;78:229–32.
17.  Data from the 2009 Annual Review of the Center for Vaccination 
and Epidemiology, Institute for Hygiene and the Environment, 
Hamburg (Germany) [cited 2010 Nov 15]. http://www.hamburg.de/
epidemiologische-berichte/2463510/jahresbericht-2009-infektion-
sepidemiologie.html
18.  Marinova L, Kojouharova M, Mihneva Z. An ongoing measles out-
break in Bulgaria, 2009. Euro Surveill. 2009;14:pii:19259. 
19.  Marinova L, Muscat M, Mihneva Z, Kojouharova M. An update on 
an ongoing measles outbreak in Bulgaria, April–November 2009. 
Euro Surveill. 2009;14. pii: 19442.
20.  Ministry of Health,National Centre of Infectious and Parasitic Dis-
eases, Sofi a, Bulgaria 2007–2010 [in Bulgarian] [cited 2010 Apr 
27]. http://www.ncipd.org/?news=disease#28
21.  Rogalska J, Santibanez S, Mankertz A, Makowka A, Szenborn L, 
Stefanoff P. Spotlight on measles 2010: an epidemiological over-
view of measles outbreaks in Poland in relation to the measles elimi-
nation goal. Euro Surveill. 2010;15:pii:19549.
22.  Velicko I, Müller LL, Pebody R, Gergonne B, Aidyralieva C, Kos-
tiuchenko N, et al. Nationwide measles epidemic in Ukraine: the 
effect of low vaccine effectiveness. Vaccine. 2008;26:6980–5. 
doi:10.1016/j.vaccine.2008.09.012
23.  Pervanidou D, Horefti E, Patrinos S, Lytras T, Triantafi llou E, Men-
tis A, et al. Spotlight on measles 2010: ongoing measles outbreak in 
Greece, January–July 2010. Euro Surveill. 2010;15:pii:19629.
24.  Gee S, Cotter S, O’Flanagan D. Spotlight on measles 2010: measles 
outbreak in Ireland 2009–2010. Euro Surveill. 2010;15. pii: 19500.
25.  Curtale F, Perrelli F, Mantovani J, Atti MC, Filia A, Nicoletti L, 
et al. Description of two measles outbreaks in the Lazio Region, 
Italy (2006–2007). Importance of pockets of low vaccine cov-
erage in sustaining the infection. BMC Infect Dis. 2010;10:62. 
doi:10.1186/1471-2334-10-62
26.  Lopalco PL, Martin R. Measles still spreads in Europe: who is respon-
sible for the failure to vaccinate? Euro Surveill. 2010;15:pii:19557.
Address for correspondence: Annette Mankertz, National Reference 
Centre for Measles, Mumps, Rubella, Germany, Regional Reference 
Laboratory WHO EUR, Viral Infections, Robert-Koch Institut, Nordufer 
20, D-13353 Berlin, Germany; email: mankertza@rki.de 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 8, August 2011 1401
All material published in Emerging Infectious Diseases is in 
the public domain and may be used and reprinted without 
special permission; proper citation, however, is required.
Use of trade names is for identifi cation only and does not 
imply endorsement by the Public Health Service or by the US 
Department of Health and Human Services.
